Cargando…
Adherence and quality of life in adults and children during 3-years of SLIT treatment with Grazax—a real life study
Respiratory allergic disease represents a global health problem, 30% of the population suffers from allergic rhinoconjunctivitis and 20% suffer from asthma. Allergy immunotherapy induce immunological tolerance and thereby modify the response to allergens and sublingual immunotherapy (SLIT) offers th...
Autores principales: | Kiotseridis, Hampus, Arvidsson, Peter, Backer, Vibeke, Braendholt, Vagn, Tunsäter, Alf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5809499/ https://www.ncbi.nlm.nih.gov/pubmed/29434271 http://dx.doi.org/10.1038/s41533-018-0072-z |
Ejemplares similares
-
Grass pollen allergy in children and adolescents-symptoms, health related quality of life and the value of pollen prognosis
por: Kiotseridis, Hampus, et al.
Publicado: (2013) -
Cognitive dysfunction and quality of life during pollen season in children with seasonal allergic rhinitis
por: Papapostolou, Georgia, et al.
Publicado: (2020) -
Economic evaluation of SQ-standardized grass allergy immunotherapy tablet (Grazax(®)) in children
por: Ronaldson, Sarah, et al.
Publicado: (2014) -
IgE sensitization in a cohort of adolescents in southern Sweden and its relation to allergic symptoms
por: Sterner, Therese, et al.
Publicado: (2019) -
Critical appraisal of Timothy grass pollen extract GRAZAX(®) in the management of allergic rhinitis
por: Scaparrotta, Alessandra, et al.
Publicado: (2015)